Wednesday - November 26, 2025
FDA Issues Warning Letter to Distacart
November 26, 2025
WASHINGTON, Nov. 26 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Distacart Inc. from the Center for Drug Evaluation and Research:

* * *

Recipient: Venkata Vamsi Krishna Kothuri, Distacart Inc., 883 N Shoreline Blvd, Suite B220, Mountain View, CA 94043, United States, happy@distacart.com

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products